Pharmacy Policies
These pharmacy policies apply to Medicare Advantage plans and the MyCare Ohio (Medicare-Medicaid) plan.
The policies below are in PDF format. If you do not have Adobe Acrobat Reader, you may download it here.
Current Pharmacy Policies
A
- Abraxane (paclitaxel albumin-bound suspension, intravenous infusion – Celgene, generic)
- Aduhelm® (aducanumab-avwa intravenous infusion – Biogen/Eisai)
- Alimta (pemetrexed intravenous infusion – Eli Lilly, generics)
- Aranesp® (darbepoetin alfa intravenous or subcutaneous injection − Amgen)
- Atgam® (lymphocyte immune globulin, anti-thymocyte globulin [equine] intravenous infusion – Pfizer)
B
C
D
F
H
I
K
L
O
P
S
T
U
Z
Cell and Gene Therapy Outcomes Tracking Program
CareSource Ohio MyCare partners with Audaire Health to capture and assess clinical benefits of Cell and Gene therapies. For more information, please refer to the CareSource Audaire Health™ Cell and Gene Therapy (CGT) Outcomes Tracking Program – Frequently Asked Questions for Providers. You can also find information about the program on our Updates & Announcements page.